IMPACT OF LOCOREGIONAL THERAPIES ON SURVIVAL IN HCC PATIENTS LISTED FOR LIVER TRANSPLANTATION

被引：0
|
作者：
Gyoeri, Georg [1 ]
Felsenreich, Moritz [1 ]
Silberhumer, Gerd [1 ]
Soliman, Thomas [1 ]
Sieghart, Wolfgang [2 ]
Berlakovich, Gabriela A. [1 ]
机构：
[1] Med Univ Vienna, Dept Transplantat, Vienna, Austria
[2] Med Univ Vienna, Dept Hepatol, Vienna, Austria
来源：
TRANSPLANT INTERNATIONAL | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
O239
引用
收藏
页码：89 / 89
页数：1
相关论文
共 50 条
  • [41] IMPACT OF GENDER ON SURVIVAL AMONG PATIENTS WITH CYSTIC FIBROSIS LISTED FOR LUNG TRANSPLANTATION
    Kirkby, S. E.
    Kopp, B. T.
    Tobias, J.
    Patel, A.
    McCoy, K. S.
    PEDIATRIC PULMONOLOGY, 2015, 50 : 372 - 372
  • [42] Predictive Value of mRECIST in HCC Response to the Neoadjuvant Locoregional Therapies and Prognosis Affected by the Peak AFP Level before Liver Transplantation.
    Xu, M.
    Fraum, T.
    Garcia-Aroz, S.
    Vachharajani, N.
    Saad, N.
    Fowler, K.
    Lin, Y.
    Chapman, W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 724 - 724
  • [43] THE EFFECT OF ADMINISTRATION OF NEOADJUVANT LOCOREGIONAL THERAPY ON THE OUTCOME OF LIVER TRANSPLANTATION FOR HCC PATIENTS WITHIN DIFFERENT TRANSPLANT CRITERIA
    Abdelfattah, Mohamed
    Elsiesy, Hussein
    Almanea, Hadeel
    Broering, Dieter
    TRANSPLANT INTERNATIONAL, 2017, 30 : 404 - 404
  • [44] TACE While Listed for Liver Transplantation Decreases the Need for HCC Exception Points
    Bhatia, Arvin K.
    Eswaran, Sheila L.
    Dhillon, Sonu
    Pierce, Kenneth
    Borge, Marc
    Brems, John
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 444 - 444
  • [45] Do tumor characteristics and locoregional therapy predict survival after OLT in patients with primary liver malignancy (HCC)?
    Kohla, M.
    Shaw, R.
    Hisatake, G.
    Osorio, R.
    Bonacini, M.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S150 - S150
  • [46] IMPACT OF OBESITY ON SURVIVAL IN PATIENTS UNDERGOING LIVER TRANSPLANTATION
    Torres-Quevedo, R.
    Rubin, A.
    San Juan, F.
    Moya, A.
    Aguilera, V.
    Prieto, M.
    Mir, J.
    Berenguer, M.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S198 - S198
  • [47] IMPACT OF NIVOLUMAB ALONE OR IN COMBINATION WITH LOCOREGIONAL THERAPIES IN HCC PATIENTS: REAL WORLD DATA FROM A SINGLE COMMUNITY CENTER
    Abdelgelil, Noha
    Hefner, Anna Marie
    Suliman, Idrees
    Hassanein, Amir
    Barakat, Fatma
    Oliver, Deanna
    Nichols, Clinton
    Dente, John
    Lyon, James
    Hassanein, Tarek
    HEPATOLOGY, 2020, 72 : 695A - 695A
  • [48] DOES LATE RECURRENCE AFTER HEPATECTOMY FOR HCC IMPACT ON SURVIVAL AFTER LIVER TRANSPLANTATION FOR HCC RECURRENCE? A CASE REPORT
    Sapisochin, Gonzalo
    Dopazo, Cristina
    Rodriguez, Roberto
    Espin, Francesc
    Castells, Luis
    Caralt, Mireia
    Lazaro, Jose Luis
    Bilbao, Itxarone
    Charco, Ramon
    TRANSPLANT INTERNATIONAL, 2011, 24 : 238 - 238
  • [49] Predicting survival among patients listed for liver transplantation: An assessment of serial MELD measurements
    Bambha, K
    Kim, WR
    Kremers, WK
    Therneau, TM
    Kamath, PS
    Wiesner, R
    Rosen, CB
    Thostenson, J
    Benson, JT
    Dickson, ER
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (11) : 1798 - 1804
  • [50] Increased need of locoregional therapies is a surrogate of tumor biology in patients undergoing liver transplantation for hepatocellular carcinoma
    Gorgen, A.
    McCluskey, S.
    McCluskey, S.
    Zhu, M.
    Abreu, P.
    Hansen, B. E.
    Ghanekar, A.
    Lilly, L.
    Cattral, M.
    Galvin, Z.
    Selzner, M.
    Bhat, M.
    Selzner, N.
    McGilvray, I
    Greig, P. D.
    Grant, D. R.
    Sapisochin, G.
    TRANSPLANTATION, 2019, 103 (08) : 54 - 54
12345